Signal Transduction
Stem Cells
Signaling Pathways
Product Type
All Products
New Products
Small Molecules
Peptides
Controlled Substances
Toxins
Caged Compounds
Fluorescent Probes
Screening Libraries
Ligand Sets
Other Product Types
Research Area
Cancer
Cardiovascular System
Endocrinology
Immunology
Neuroscience
Pain & Inflammation
Respiratory System
Cdc25 Phosphatase
More Information »Cdc25 is a dual specificity phosphatase with three isoforms in mammalian cells - cdc25A, B and C. It is a key mediator of cell cycle progression. Cdc25 regulation occurs through phosphorylation, interaction with 14.3.3 proteins, subcellular localization and protein degradation.
Cdc25 Phosphatase Products
Inhibitors |
|
Cat.No. |
Product Name / Activity |
| 1867 | NSC 663284 |
| Potent, selective Cdc25 phosphatase inhibitor | |
| 1547 | NSC 95397 |
| Selective Cdc25 dual specificity phosphatase inhibitor | |
Related Categories
Quick Order
Find multiple products by catalog number
Cancer Research Guide
Request your free copy
Highlights over 350 products for cancer research. Request a copy or view PDF today.
Checkpoint Kinases & the DNA Damage Response
Written by Michelle D. Garrett and Ian Collins
A summary of the response of the checkpoint kinase signaling network to DNA damage, including activation of DNA repair, cell-cycle arrest, senescence and apoptosis.
The p53 Tumor Suppressor Response
Written by Christopher J. Brown et al
A summary of the main strategies that may be utilized to reactivate p53 including several small molecules and peptides which act to stabilize p53 and rescue wild-type activity.
20% Discount*
Potent, selective LRRK2 inhibitor
Tocris is the first to launch GSK2578215A, licensed from GlaxoSmithKline, for the study of Parkinson's Disease.